• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开始异烟肼预防治疗前进行症状和胸部 X 线筛查以发现传染性肺结核:筛查中的检出率和漏诊率。

Symptom and chest radiographic screening for infectious tuberculosis prior to starting isoniazid preventive therapy: yield and proportion missed at screening.

机构信息

Aurum Institute for Health Research, Johannesburg, South Africa.

出版信息

AIDS. 2010 Nov;24 Suppl 5:S19-27. doi: 10.1097/01.aids.0000391018.72542.46.

DOI:10.1097/01.aids.0000391018.72542.46
PMID:21079424
Abstract

OBJECTIVE

This analysis describes the prevalence of and risk factors for tuberculosis at screening prior to isoniazid preventive therapy (IPT); the additional yield of tuberculosis using chest radiography versus symptoms alone, and risk factors for tuberculosis missed by screening.

DESIGN

Cross-sectional analysis of a trial of community-wide IPT in South African gold mines.

METHODS

Participants were screened for tuberculosis prior to starting IPT using symptoms (cough >2 weeks, weight loss, night sweats) and chest radiography. Tuberculosis suspects had sputum collected for mycobacterial investigations. Those with a positive smear or culture with no speciation or culture identified as Mycobacterium tuberculosis were classified as having probable or definite tuberculosis, respectively. Among participants who were dispensed IPT, we defined a 'missed' case of active tuberculosis as one identified within 90 days of the enrolment screen.

RESULTS

Between July 2006 and December 2008, among 23,286 participants with complete data, the prevalence of undiagnosed tuberculosis [definite (284) and probable (31)] was high (315/23 286; 1.4%). The addition of chest radiography to symptom screening increased the number of definite tuberculosis cases detected by 2.5-fold (113 to 281 cases). Among 19,609 individuals correctly screened for tuberculosis who started IPT and had more than 90 days of follow-up, only 39 (0.2%) active tuberculosis cases were missed. Risk factors for tuberculosis missed by screening included increasing age [adjusted odds ratio (aOR) 1.66/10 year increase, 95% confidence interval (CI) 1.07-2.56], non-South African, in HIV care (aOR 4.80, 95% CI 1.63-14.1), lower weight (aOR 2.07/10 kg decrease, 95% CI 1.23-3.49) and alcohol use (aOR 2.52, 95% CI 1.31-4.86), which were similar to risk factors for tuberculosis detected by screening.

CONCLUSION

Tuberculosis screening prior to IPT detects a substantial burden of tuberculosis and misses very few cases. Chest radiography significantly increased the yield of tuberculosis cases detected.

摘要

目的

本分析描述了异烟肼预防性治疗(IPT)前筛查中结核病的患病率和危险因素;与仅使用症状相比,胸部 X 射线检查对结核病的额外检出率,以及筛查遗漏的结核病危险因素。

设计

南非金矿社区范围 IPT 试验的横断面分析。

方法

参与者在开始 IPT 前使用症状(咳嗽>2 周、体重减轻、盗汗)和胸部 X 射线进行结核病筛查。疑似结核病者采集痰液进行分枝杆菌检查。那些痰涂片阳性或培养阳性但未鉴定或培养出结核分枝杆菌的患者,分别被归类为可能或确诊结核病。在接受 IPT 配药的参与者中,我们将活动性结核病的“漏诊”病例定义为在登记筛查后 90 天内确诊的病例。

结果

2006 年 7 月至 2008 年 12 月,在 23286 名完成数据的参与者中,未确诊结核病[确诊(284 例)和可能(31 例)]的患病率较高(315/23286;1.4%)。将胸部 X 射线检查添加到症状筛查中,使确诊结核病的病例数增加了 2.5 倍(113 例至 281 例)。在 19609 名正确筛查结核病并随访超过 90 天的开始接受 IPT 的个体中,仅发现 39 例(0.2%)活动性结核病漏诊。筛查遗漏的结核病的危险因素包括年龄增加[校正优势比(aOR)每增加 10 岁为 1.66,95%置信区间(CI)为 1.07-2.56]、非南非人、HIV 治疗中(aOR 4.80,95%CI 1.63-14.1)、体重减轻(aOR 2.07/10kg 下降,95%CI 1.23-3.49)和饮酒(aOR 2.52,95%CI 1.31-4.86),与通过筛查发现的结核病危险因素相似。

结论

IPT 前的结核病筛查发现了大量结核病病例,漏诊病例很少。胸部 X 射线检查显著提高了结核病病例的检出率。

相似文献

1
Symptom and chest radiographic screening for infectious tuberculosis prior to starting isoniazid preventive therapy: yield and proportion missed at screening.开始异烟肼预防治疗前进行症状和胸部 X 线筛查以发现传染性肺结核:筛查中的检出率和漏诊率。
AIDS. 2010 Nov;24 Suppl 5:S19-27. doi: 10.1097/01.aids.0000391018.72542.46.
2
Adverse events with isoniazid preventive therapy: experience from a large trial.异烟肼预防治疗的不良反应:一项大型试验的经验。
AIDS. 2010 Nov;24 Suppl 5:S29-36. doi: 10.1097/01.aids.0000391019.10661.66.
3
Pulmonary tuberculosis screening in anti-retroviral treated adults living with HIV in Kenya.肯尼亚接受抗逆转录病毒治疗的艾滋病毒感染者中的肺结核筛查。
BMC Infect Dis. 2021 Feb 25;21(1):218. doi: 10.1186/s12879-021-05916-z.
4
The timing of tuberculosis after isoniazid preventive therapy among gold miners in South Africa: a prospective cohort study.南非金矿工人接受异烟肼预防性治疗后患结核病的时间:一项前瞻性队列研究。
BMC Med. 2016 Mar 23;14:45. doi: 10.1186/s12916-016-0589-3.
5
Tuberculosis outcomes and drug susceptibility in individuals exposed to isoniazid preventive therapy in a high HIV prevalence setting.高 HIV 流行环境中异烟肼预防性治疗暴露者的结核病结局和药物敏感性。
AIDS. 2010 Apr 24;24(7):1051-5. doi: 10.1097/QAD.0b013e32833849df.
6
Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial.异烟肼联合抗逆转录病毒疗法预防结核病:一项随机、双盲、安慰剂对照试验。
Lancet. 2014 Aug 23;384(9944):682-90. doi: 10.1016/S0140-6736(14)60162-8. Epub 2014 May 13.
7
Eligibility for isoniazid preventive therapy in South African gold mines.南非金矿中异烟肼预防性治疗的适用性。
PLoS One. 2013 Nov 14;8(11):e81376. doi: 10.1371/journal.pone.0081376. eCollection 2013.
8
Evaluation of the Isoniazid Preventive Therapy Care Cascade Among HIV-Positive Female Sex Workers in Mombasa, Kenya.肯尼亚蒙巴萨地区感染艾滋病毒的女性性工作者中异烟肼预防性治疗服务流程的评估
J Acquir Immune Defic Syndr. 2017 Sep 1;76(1):74-81. doi: 10.1097/QAI.0000000000001461.
9
Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.南非感染 HIV 的成年人中异烟肼预防治疗、高效抗逆转录病毒治疗和结核病风险:一项前瞻性队列研究。
AIDS. 2009 Mar 13;23(5):631-6. doi: 10.1097/QAD.0b013e328327964f.
10
Screening for tuberculosis prior to isoniazid preventive therapy among HIV-infected gold miners in South Africa.在南非感染艾滋病毒的金矿工人中,在进行异烟肼预防性治疗之前进行结核病筛查。
Int J Tuberc Lung Dis. 2006 May;10(5):523-9.

引用本文的文献

1
Number needed to screen for TB in clinical, structural or occupational risk groups.筛查临床、结构或职业风险人群中的结核病所需的人数。
Int J Tuberc Lung Dis. 2022 Jun 1;26(6):500-508. doi: 10.5588/ijtld.21.0749.
2
Symptom- and chest-radiography screening for active pulmonary tuberculosis in HIV-negative adults and adults with unknown HIV status.症状和胸部 X 线筛查在 HIV 阴性的成年人和 HIV 状态未知的成年人中的活动性肺结核。
Cochrane Database Syst Rev. 2022 Mar 23;3(3):CD010890. doi: 10.1002/14651858.CD010890.pub2.
3
Systematic screening for tuberculosis among hospital outpatients in Cameroon: The role of screening and testing algorithms to improve case detection.
喀麦隆医院门诊患者中结核病的系统筛查:筛查和检测算法在提高病例发现率方面的作用。
J Clin Tuberc Other Mycobact Dis. 2019 Feb 18;15:100095. doi: 10.1016/j.jctube.2019.100095. eCollection 2019 May.
4
Time delay and associated mortality from negative smear to positive Xpert MTB/RIF test among TB/HIV patients: a retrospective study.结核/艾滋病毒患者中阴性涂片到 Xpert MTB/RIF 检测阳性的时间延迟及相关死亡率:一项回顾性研究。
BMC Infect Dis. 2019 Jan 7;19(1):18. doi: 10.1186/s12879-018-3656-x.
5
The value of laboratory tests in the diagnosis of tuberculosis.实验室检查在结核病诊断中的价值。
Clujul Med. 2017;90(2):185-187. doi: 10.15386/cjmed-650. Epub 2017 Apr 25.
6
Who Has Mycobacterial Disease? A Cross Sectional Study in Agropastoral Communities in Tanzania.谁患有分枝杆菌病?坦桑尼亚农牧社区的横断面研究。
PLoS One. 2016 May 23;11(5):e0153711. doi: 10.1371/journal.pone.0153711. eCollection 2016.
7
Clinical Relevance of Nontuberculous Mycobacteria Isolated from Sputum in a Gold Mining Workforce in South Africa: An Observational, Clinical Study.从南非金矿工人痰液中分离出的非结核分枝杆菌的临床相关性:一项观察性临床研究
Biomed Res Int. 2015;2015:959107. doi: 10.1155/2015/959107. Epub 2015 May 28.
8
Eligibility for isoniazid preventive therapy in South African gold mines.南非金矿中异烟肼预防性治疗的适用性。
PLoS One. 2013 Nov 14;8(11):e81376. doi: 10.1371/journal.pone.0081376. eCollection 2013.
9
Community-wide isoniazid preventive therapy drives drug-resistant tuberculosis: a model-based analysis.全社区异烟肼预防治疗可推动耐药结核病的防控:基于模型的分析。
Sci Transl Med. 2013 Apr 10;5(180):180ra49. doi: 10.1126/scitranslmed.3005260.
10
Screening and rapid molecular diagnosis of tuberculosis in prisons in Russia and Eastern Europe: a cost-effectiveness analysis.俄罗斯和东欧监狱中结核病的筛查和快速分子诊断:成本效益分析。
PLoS Med. 2012;9(11):e1001348. doi: 10.1371/journal.pmed.1001348. Epub 2012 Nov 27.